Back
Candel Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
75
CADL
Candel Therapeutics, Inc.
Last Price:
$5.88
Seasonality Move:
2.55%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CADL is experiencing slight buying pressure.
Candel Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.86 | Buy |
| 20-day SMA: | 5.33 | Buy |
| 50-day SMA: | 5.25 | Buy |
| 200-day SMA: | 5.62 | Buy |
| 8-day EMA: | 5.71 | Buy |
| 20-day EMA: | 5.48 | Buy |
| 50-day EMA: | 5.34 | Buy |
| 200-day EMA: | 5.63 | Buy |
Candel Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 60.43 | Buy |
| Chaikin Money Flow: | 394403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.55 - 5.81) | Buy |
| Bollinger Bands (100): | (4.87 - 5.97) | Buy |
Candel Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Candel Therapeutics, Inc. Stock
Is Candel Therapeutics, Inc. Stock a Buy?
-
Candel Therapeutics, Inc. share price is 5.94 while CADL 8-day simple moving average is 5.86, which is a Buy signal.
-
The stock price of CADL is 5.94 while Candel Therapeutics, Inc. 20-day SMA is 5.33, which makes it a Buy.
-
Candel Therapeutics, Inc. 50-day simple moving average is 5.25 while CADL share price is 5.94, making it a Buy technically.
-
CADL stock price is 5.94 and Candel Therapeutics, Inc. 200-day simple moving average is 5.62, creating a Buy signal.
CADL Technical Analysis vs Fundamental Analysis
Buy
75
Candel Therapeutics, Inc. (CADL)
is a Buy
Is Candel Therapeutics, Inc. a Buy or a Sell?
-
Candel Therapeutics, Inc. stock is rated a BuyThe current Candel Therapeutics, Inc. [CADL] share price is $5.94. The Score for CADL is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
Candel Therapeutics, Inc. Stock Info
Market Cap:
326.1M
Price in USD:
5.94
Share Volume:
933.8K
Candel Therapeutics, Inc. 52-Week Range
52-Week High:
13.68
52-Week Low:
4.25
Buy
75
Candel Therapeutics, Inc. (CADL)
is a Buy
Candel Therapeutics, Inc. Share Price Forecast
-
What is the Candel Therapeutics, Inc. stock price today?The Candel Therapeutics, Inc. stock price is 5.94 USD today.
-
Will CADL stock go up or go down?Candel Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Candel Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Candel Therapeutics, Inc. is not overvalued.
Is Candel Therapeutics, Inc. Stock a Buy?
-
Candel Therapeutics, Inc. share price is 5.94 while CADL 8-day exponential moving average is 5.71, which is a Buy signal.
-
The stock price of CADL is 5.94 while Candel Therapeutics, Inc. 20-day EMA is 5.48, which makes it a Buy.
-
Candel Therapeutics, Inc. 50-day exponential moving average is 5.34 while CADL share price is 5.94, making it a Buy technically.
-
CADL stock price is 5.94 and Candel Therapeutics, Inc. 200-day simple moving average is 5.63, creating a Buy signal.
Fundamental Analysis of Candel Therapeutics, Inc.
Is Candel Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.11 per share.
Technical Analysis of Candel Therapeutics, Inc.
Should I short Candel Therapeutics, Inc. stock?
-
CADL Moving Average Covergence Divergence (MACD) indicator is 0.22, suggesting Candel Therapeutics, Inc. is a Buy
-
Candel Therapeutics, Inc. Relative Strength Index (RSI) is 60.43, which suggest Candel Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Candel Therapeutics, Inc. is (4.55 - 5.81), which suggest Candel Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Candel Therapeutics, Inc. is (4.87 - 5.97), which suggest Candel Therapeutics, Inc. is a Buy
* Candel Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.